HC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 90.4%

Neg 0% Neu 90.4% Pos 0%

HC Wainwright & Co. analyst Joseph Pantginis reiterates Fractyl Health (NASDAQ:GUTS) with a Buy and maintains $8 price target.